James Grube's Insider Trades & SAST Disclosures
James Grube's most recent trade in Eton Pharmaceuticals Inc was a trade of 38,621 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Grube.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 38,621 | 38,621 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,876 | 25,876 | - | - | Restricted Stock Units | |
| Eton Pharmaceuticals Inc | R. Gruber James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 144,677 | 374,763 | - | - | Stock Option (Right to buy) | |
| Gamestop Corporation - Ord... | James Grube | Director | Grant, award, or other acquisition of securities at price $ 22.80 per share. | 15 Jun 2023 | 8,772 | 23,864 (0%) | 0% | 22.8 | 200,002 | Class A Common Stock |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 100,086 | 200,086 | - | - | Stock Option (right to buy) | |
| Eton Pharmaceuticals Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Gamestop Corporation - Ord... | James Grube | Director | Grant, award, or other acquisition of securities at price $ 114.32 per share. | 15 Jun 2022 | 1,750 | 3,773 (0%) | 0% | 114.3 | 200,060 | Class A Common Stock |
| Gamestop Corporation - Ord... | James Grube | Director | Sale of securities on an exchange or to another person at price $ 217.78 per share. | 23 Jun 2021 | 1,900 | 2,023 (0%) | 0% | 217.8 | 413,782 | Class A Common Stock |
| Gamestop Corporation - Ord... | James Grube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,022 | 3,923 (0%) | 0% | 0 | Class A Common Stock | |
| Gamestop Corporation - Ord... | James Grube | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,901 | 2,901 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges